{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:15:22Z","timestamp":1793646922842,"version":"4.5.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T00:00:00Z","timestamp":1304726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11894-011-0197-5","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T03:05:23Z","timestamp":1304651123000},"page":"323-330","source":"Crossref","is-referenced-by-count":77,"title":["The Role of Eosinophils and Mast Cells in Intestinal Functional Disease"],"prefix":"10.1007","volume":"13","author":[{"given":"Marjorie M.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"Warwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuin","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,7]]},"reference":[{"key":"197_CR1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","volume":"130","author":"DA Drossman","year":"2006","unstructured":"Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377\u201390.","journal-title":"Gastroenterology"},{"key":"197_CR2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1053\/j.gastro.2005.04.020","volume":"128","author":"DA Drossman","year":"2005","unstructured":"Drossman DA. Functional GI disorders: what\u2019s in a name? Gastroenterology. 2005;128:1771\u20132.","journal-title":"Gastroenterology"},{"key":"197_CR3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2982.2008.01220.x","volume":"21","author":"S Kindt","year":"2009","unstructured":"Kindt S, Van Oudenhove L, Broekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil. 2009;21:389\u201398.","journal-title":"Neurogastroenterol Motil"},{"key":"197_CR4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5056\/jnm.2010.16.3.251","volume":"16","author":"KJ Lee","year":"2010","unstructured":"\u2022\u2022 Lee KJ, Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil. 2010; 16:251\u20137. An interesting paper highlighting the importance of the duodenum as the seat of symptoms in FD.","journal-title":"J Neurogastroenterol Motil"},{"key":"197_CR5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2036.2009.04047.x","volume":"30","author":"AP Hungin","year":"2009","unstructured":"Hungin AP, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther. 2009;30:331\u201342.","journal-title":"Aliment Pharmacol Ther"},{"key":"197_CR6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1542-3565(05)00153-9","volume":"3","author":"M Camilleri","year":"2005","unstructured":"Camilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3:543\u201352.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"197_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2036.1996.tb00180.x","volume":"10","author":"JG Penston","year":"1996","unstructured":"Penston JG, Pounder RD. A survey of dyspepsia in Great Britain. Aliment Pharm Ther. 1996;10:83\u20139.","journal-title":"Aliment Pharm Ther"},{"key":"197_CR8","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J Tack","year":"2006","unstructured":"Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466\u201379.","journal-title":"Gastroenterology"},{"key":"197_CR9","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2005.09.020","volume":"129","author":"NJ Talley","year":"2005","unstructured":"Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005;129:1756\u201380.","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"197_CR10","doi-asserted-by":"crossref","first-page":"II37","DOI":"10.1136\/gut.45.2008.ii37","volume":"45","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Stanghellini V, Heading R, et al. Functional gastroduodenal disorders: a working team report for the Rome II consensus on functional gastrointestinal disorders. Gut. 1999;45 Suppl 2:II37\u201342.","journal-title":"Gut"},{"key":"197_CR11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","volume":"110","author":"V Stanghellini","year":"1996","unstructured":"Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996;110:1036\u201342.","journal-title":"Gastroenterology"},{"key":"197_CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","volume":"98","author":"G Sarnelli","year":"2003","unstructured":"Sarnelli G, Caenepeel P, Geypens B, et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003;98:783\u20138.","journal-title":"Am J Gastroenterol"},{"key":"197_CR13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/gast.2001.27180","volume":"121","author":"J Tack","year":"2001","unstructured":"Tack J, Caenepeel P, Fischler B, et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology. 2001;121:526\u201335.","journal-title":"Gastroenterology"},{"key":"197_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/000992280604500205","volume":"45","author":"CA Friesen","year":"2006","unstructured":"Friesen CA, Sandridge L, Andre L, et al. Mucosal eosinophilia and response to H1\/H2 antagonist and cromolyn therapy in pediatric dyspepsia. Clin Pediatr (Phila). 2006;45:143\u20137.","journal-title":"Clin Pediatr (Phila)"},{"key":"197_CR15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cgh.2007.05.015","volume":"5","author":"NJ Talley","year":"2007","unstructured":"\u2022 Talley NJ, Walker MM, Aro P, et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol. 2007; 5:1175\u201383. The first study to implicate eosinophils in the duodenum in functional dyspepsia in adults.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"197_CR16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2036.2009.03937.x","volume":"29","author":"MM Walker","year":"2009","unstructured":"Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009;29:765\u201373.","journal-title":"Aliment Pharmacol Ther"},{"key":"197_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00005176-200209000-00017","volume":"35","author":"CA Friesen","year":"2002","unstructured":"Friesen CA, Andre L, Garola R, et al. Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study. J Pediatr Gastroenterol Nutr. 2002;35:329\u201333.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"197_CR18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-230X-9-32","volume":"9","author":"CA Friesen","year":"2009","unstructured":"\u2022 Friesen CA, Neilan NA, Schurman JV, et al. Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics. BMC Gastroenterol. 2009; 9:32. A study of treatment of functional dyspepsia in children relating this to pathophysiology.","journal-title":"BMC Gastroenterol"},{"key":"197_CR19","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1084\/jem.182.6.1897","volume":"182","author":"B Wallaert","year":"1995","unstructured":"Wallaert B, Desreumaux P, Coplin MC, et al. Immunoreactivity for interleukin 3 and 5 granulocyte\/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med. 1995;182:1897\u2013904.","journal-title":"J Exp Med"},{"key":"197_CR20","first-page":"253","volume":"25","author":"GV Pires","year":"2004","unstructured":"Pires GV, Souza HS, Elia CC, et al. Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation. Allergy Asthma Proc. 2004;25:253\u20139.","journal-title":"Allergy Asthma Proc"},{"key":"197_CR21","first-page":"1026","volume":"57","author":"N Powell","year":"2008","unstructured":"Powell N, Huntley B, Beech T, Knight W. Upper gastrointestinal symptoms and asthma: a manifestation of allergy? Gut. 2008;57:1026\u20137.","journal-title":"Gut"},{"key":"197_CR22","first-page":"229","volume":"311","author":"MM Walker","year":"2010","unstructured":"Walker MM, Salehian SS, Murray CE, et al. Implications of eosinophilia in the normal duodenal biopsy\u2014an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010;311:229\u201336.","journal-title":"Aliment Pharmacol Ther"},{"key":"197_CR23","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/ajg.2010.151","volume":"105","author":"S Futagami","year":"2010","unstructured":"Futagami S, Shindo T, Kawagoe T, et al. Migration of Eosinophils and CCR2-\/CD68-Double Positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia. Am J Gastroenterol. 2010;105:1835\u201342.","journal-title":"Am J Gastroenterol"},{"key":"197_CR24","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1007\/s10620-008-0207-0","volume":"53","author":"CA Friesen","year":"2008","unstructured":"Friesen CA, Lin Z, Singh M, et al. Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci. 2008;53:2634\u201340.","journal-title":"Dig Dis Sci"},{"key":"197_CR25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/S1542-3565(03)00184-8","volume":"1","author":"W Hall","year":"2003","unstructured":"Hall W, Buckley M, Crotty P, et al. Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin Gastroenterol Hepatol. 2003;1:363\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"197_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2036.2004.01974.x","volume":"20","author":"S Nakajima","year":"2004","unstructured":"Nakajima S, Bamba N, Hattori T. Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis. Aliment Pharmacol Ther. 2004;20 Suppl 1:165\u201370.","journal-title":"Aliment Pharmacol Ther"},{"key":"197_CR27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/00365521003632576","volume":"45","author":"X Li","year":"2010","unstructured":"Li X, Chen H, Lu H, et al. The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia. Scand J Gastroenterol. 2010;45:573\u201381.","journal-title":"Scand J Gastroenterol"},{"key":"197_CR28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MPG.0b013e3181d1363c","volume":"51","author":"JV Schurman","year":"2010","unstructured":"Schurman JV, Singh M, Singh V, et al. Symptoms and subtypes in pediatric functional dyspepsia: relation to mucosal inflammation and psychological functioning. J Pediatr Gastroenterol Nutr. 2010;51:298\u2013303.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"197_CR29","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480\u201391.","journal-title":"Gastroenterology"},{"key":"197_CR30","first-page":"1910","volume":"97","author":"YA Saito","year":"2002","unstructured":"Saito YA, Schoenfeld P, Locke 3rd GR. The epidemiology of irritable bowel syndrome in North America: a systematic review. Aliment Pharmacol Ther. 2002;97:1910\u20135.","journal-title":"Aliment Pharmacol Ther"},{"key":"197_CR31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5056\/jnm.2010.16.1.30","volume":"16","author":"KA Gwee","year":"2010","unstructured":"Gwee KA. Post-infectious irritable bowel syndrome, an inflammation-immunological model with relevance for other IBS and functional dyspepsia. J Neurogastroenterol Motil. 2010;16:30\u20134.","journal-title":"J Neurogastroenterol Motil"},{"key":"197_CR32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/pgmj.2006.049585","volume":"83","author":"N Powell","year":"2007","unstructured":"Powell N, Huntley B, Beech T, et al. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J. 2007;83:182\u20136.","journal-title":"Postgrad Med J"},{"key":"197_CR33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/gut.2006.100594","volume":"56","author":"M Guilarte","year":"2007","unstructured":"Guilarte M, Santos J, de Torres I, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56:203\u20139.","journal-title":"Gut"},{"key":"197_CR34","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/BF01303164","volume":"38","author":"AP Weston","year":"1993","unstructured":"Weston AP, Biddle WL, Bhatia PS, Miner Jr PB. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci. 1993;38:1590\u20135.","journal-title":"Dig Dis Sci"},{"key":"197_CR35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","volume":"12","author":"M O\u2019Sullivan","year":"2000","unstructured":"O\u2019Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil. 2000;12:449\u201357.","journal-title":"Neurogastroenterol Motil"},{"key":"197_CR36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.2007.127068","volume":"57","author":"T Piche","year":"2008","unstructured":"Piche T, Saint-Paul MC, Dainese R, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 2008;57:468\u201373.","journal-title":"Gut"},{"key":"197_CR37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1440-1746.2005.04143.x","volume":"21","author":"JH Park","year":"2006","unstructured":"Park JH, Rhee PL, Kim HS, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2006;21:71\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"197_CR38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ajg.2008.94","volume":"104","author":"C Cremon","year":"2009","unstructured":"Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009;104:392\u2013400.","journal-title":"Am J Gastroenterol"},{"key":"197_CR39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1440-1746.2005.04143.x","volume":"21","author":"JH Park","year":"2006","unstructured":"Park JH, Rhee PL, Kim HS, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2006;21:71\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"197_CR40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.2007.127068","volume":"57","author":"T Piche","year":"2008","unstructured":"Piche T, Saint-Paul MC, Dainese R, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 2008;57:468\u201373.","journal-title":"Gut"},{"key":"197_CR41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1746-1596-4-34","volume":"4","author":"FE Mahjoub","year":"2009","unstructured":"Mahjoub FE, Farahmand F, Pourpak Z, et al. Mast cell gastritis: children complaining of chronic abdominal pain with histologically normal gastric mucosal biopsies except for increase in mast cells, proposing a new entity. Diagn Pathol. 2009;4:34.","journal-title":"Diagn Pathol"},{"key":"197_CR42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1756-0500-3-265","volume":"3","author":"TJ Taylor","year":"2010","unstructured":"Taylor TJ, Youssef NN, Shankar R, et al. The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology. BMC Res Notes. 2010;3:265.","journal-title":"BMC Res Notes"},{"key":"197_CR43","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1053\/j.gastro.2009.02.074","volume":"136","author":"R Spiller","year":"2009","unstructured":"\u2022\u2022 Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009; 136:1979\u201388. An excellent review of this condition.","journal-title":"Gastroenterology"},{"key":"197_CR44","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/gut.2003.021154","volume":"53","author":"LH Wang","year":"2004","unstructured":"Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut. 2004;53:1096\u2013101.","journal-title":"Gut"},{"key":"197_CR45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.gastro.2004.04.006","volume":"127","author":"P Berc\u00edk","year":"2004","unstructured":"Berc\u00edk P, Wang L, Verd\u00fa EF, et al. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology. 2004;127:179\u201387.","journal-title":"Gastroenterology"},{"key":"197_CR46","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/gast.1997.v113.pm9322517","volume":"113","author":"G Barbara","year":"1997","unstructured":"Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology. 1997;113:1224\u201332.","journal-title":"Gastroenterology"},{"key":"197_CR47","doi-asserted-by":"crossref","first-page":"G1354","DOI":"10.1152\/ajpgi.00324.2010","volume":"299","author":"Y Motomura","year":"2010","unstructured":"Motomura Y, Khan WI, El-Sharkawy RT, et al. Mechanisms underlying gut dysfunction in a murine model of chronic parasitic infection. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1354\u201360.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"197_CR48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3164\/jcbn.40.24","volume":"40","author":"T Arisawa","year":"2007","unstructured":"Arisawa T, Arisawa S, Yokoi T, et al. Endoscopic and histological features of the large intestine in patients with atopic dermatitis. J Clin Biochem Nutr. 2007;40:24\u201330.","journal-title":"J Clin Biochem Nutr"},{"key":"197_CR49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11894-008-0073-0","volume":"10","author":"R Giorgio De","year":"2008","unstructured":"De Giorgio R, Barbara G. Is irritable bowel syndrome an inflammatory disorder. Curr Gastroenterol Rep. 2008;10:385\u201390.","journal-title":"Curr Gastroenterol Rep"},{"key":"197_CR50","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/icb.2009.115","volume":"88","author":"LA Spencer","year":"2010","unstructured":"\u2022 Spencer LA, Weller PF. Eosinophils and Th2 immunity: contemporary insights. Immunol Cell Biol. 2010; 88:250\u20136. A good review of this subject.","journal-title":"Immunol Cell Biol"},{"key":"197_CR51","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/eji.201040559","volume":"40","author":"SJ Galli","year":"2010","unstructured":"\u2022 Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol. 2010; 40:1843\u201351. A good review of this subject.","journal-title":"Eur J Immunol"},{"key":"197_CR52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","volume":"126","author":"G Barbara","year":"2004","unstructured":"Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693\u2013702.","journal-title":"Gastroenterology"},{"key":"197_CR53","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1053\/j.gastro.2009.07.005","volume":"137","author":"S Buhner","year":"2009","unstructured":"Buhner S, Li Q, Vignali S, et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology. 2009;137:1425\u201334.","journal-title":"Gastroenterology"},{"key":"197_CR54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2010.01.055","volume":"126","author":"D Simon","year":"2010","unstructured":"Simon D, Wardlaw A, Rothenberg ME. Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol. 2010;126:3\u201313.","journal-title":"J Allergy Clin Immunol"},{"key":"197_CR55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrgastro.2010.5","volume":"7","author":"N Powell","year":"2010","unstructured":"Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010;7:146\u201356.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"197_CR56","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.4049\/jimmunol.174.8.4453","volume":"174","author":"MT Abreu","year":"2005","unstructured":"Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol. 2005;174:4453\u201360.","journal-title":"J Immunol"},{"key":"197_CR57","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.171.8.3977","volume":"171","author":"H Nagase","year":"2003","unstructured":"Nagase H, Okugawa S, Ota Y, et al. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol. 2003;171:3977\u201382.","journal-title":"J Immunol"},{"key":"197_CR58","unstructured":"Brint EK, MacSharry J, Fanning A, et al. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol 2010 Nov 23. [Epub ahead of print]."},{"key":"197_CR59","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2009.12.049","volume":"138","author":"AC Villani","year":"2010","unstructured":"\u2022 Villani AC, Lemire M, Thabane M, et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology. 2010; 138:1502\u201313. A well conducted study from this group, who have published good studies from this cohort of patients.","journal-title":"Gastroenterology"},{"key":"197_CR60","doi-asserted-by":"crossref","first-page":"e8226","DOI":"10.1371\/journal.pone.0008226","volume":"4","author":"DP McKernan","year":"2009","unstructured":"McKernan DP, Nolan A, Brint EK, et al. Toll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndrome. PLoS ONE. 2009;4:e8226.","journal-title":"PLoS ONE"},{"key":"197_CR61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.iac.2006.05.011","volume":"26","author":"C Tkaczyk","year":"2006","unstructured":"Tkaczyk C, Jensen BM, Iwaki S, et al. Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses. Immunol Allergy Clin North Am. 2006;26:427\u201350.","journal-title":"Immunol Allergy Clin North Am"},{"key":"197_CR62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri2018","volume":"7","author":"SC Bischoff","year":"2007","unstructured":"\u2022\u2022 Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol. 2007; 7:93\u2013104. An excellent review.","journal-title":"Nat Rev Immunol"},{"key":"197_CR63","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/eji.200323830","volume":"33","author":"S Varadaradjalou","year":"2003","unstructured":"Varadaradjalou S, F\u00e9ger F, Thieblemont N, et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol. 2003;33:899\u2013906.","journal-title":"Eur J Immunol"},{"key":"197_CR64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0625.2009.00878.x","volume":"18","author":"S Mrabet-Dahbi","year":"2009","unstructured":"Mrabet-Dahbi S, Metz M, Dudeck A, et al. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol. 2009;18:437\u201344.","journal-title":"Exp Dermatol"},{"key":"197_CR65","doi-asserted-by":"crossref","first-page":"8748","DOI":"10.1073\/pnas.0912551107","volume":"107","author":"N Dietrich","year":"2010","unstructured":"Dietrich N, Rohde M, Geffers R, et al. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. PNAS. 2010;107:8748\u201353.","journal-title":"PNAS"},{"key":"197_CR66","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.0607325103","volume":"103","author":"AA Navarini","year":"2006","unstructured":"Navarini AA, Recher M, Lang KS, et al. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci USA. 2006;103:15535\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"197_CR67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.20040976","volume":"200","author":"V Auerbuch","year":"2004","unstructured":"Auerbuch V, Brockstedt DG, Meyer-Morse N, et al. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med. 2004;200:527\u201333.","journal-title":"J Exp Med"},{"key":"197_CR68","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1172\/JCI35412","volume":"119","author":"A Shahangian","year":"2009","unstructured":"Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest. 2009;119:1910\u201320.","journal-title":"J Clin Invest"},{"key":"197_CR69","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1084\/jem.20040712","volume":"200","author":"RM O\u2019Connell","year":"2004","unstructured":"O\u2019Connell RM, Saha SK, Vaidya SA, et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med. 2004;200:437\u201345.","journal-title":"J Exp Med"},{"key":"197_CR70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20040769","volume":"200","author":"JA Carrero","year":"2004","unstructured":"Carrero JA, Calderon B, Unanue ER. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J Exp Med. 2004;200:535\u201340.","journal-title":"J Exp Med"},{"key":"197_CR71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000226237","volume":"150","author":"K Kasakura","year":"2009","unstructured":"Kasakura K, Takahashi K, Aizawa T, et al. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells. Int Arch Allergy Immunol. 2009;150:359\u201369.","journal-title":"Int Arch Allergy Immunol"},{"key":"197_CR72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.gastro.2004.11.050","volume":"128","author":"L O\u2019Mahony","year":"2005","unstructured":"O\u2019Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:41\u2013551.","journal-title":"Gastroenterology"},{"key":"197_CR73","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ajg.2009.25","volume":"104","author":"D Brenner","year":"2009","unstructured":"Brenner D, Moeller M, Chey W, et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol. 2009;104:1033\u201349.","journal-title":"Am J Gastroenterol"},{"key":"197_CR74","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.170.4.1625","volume":"170","author":"JD McCurdy","year":"2003","unstructured":"McCurdy JD, Olynych TJ, Maher LH, et al. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol. 2003;170:1625\u20139.","journal-title":"J Immunol"},{"key":"197_CR75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000320557","volume":"26","author":"H Yang","year":"2010","unstructured":"Yang H, Wei J, Zhang H, et al. Upregulation of Toll-like Receptor (TLR) expression and release of cytokines from mast cells by IL-12. Cell Physiol Biochem. 2010;26:337\u201346.","journal-title":"Cell Physiol Biochem"},{"key":"197_CR76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2121-10-37","volume":"10","author":"H Yang","year":"2009","unstructured":"Yang H, Wei J, Zhang H, et al. Upregulation of Toll-like receptor (TLR) expression and release of cytokines from P815 mast cells by GM-CSF. BMC Cell Biol. 2009;10:37.","journal-title":"BMC Cell Biol"},{"key":"197_CR77","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2567.2010.03296.x","volume":"131","author":"BP Tancowny","year":"2010","unstructured":"Tancowny BP, Karpov V, Schleimer RP, et al. Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2. Immunology. 2010;131:220\u201330.","journal-title":"Immunology"},{"key":"197_CR78","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2007.138982","volume":"57","author":"A Akbar","year":"2008","unstructured":"Akbar A, Yiangou Y, Facer P, et al. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut. 2008;57:923\u20139.","journal-title":"Gut"},{"key":"197_CR79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3164\/jcbn.10-40","volume":"47","author":"T Tahara","year":"2010","unstructured":"Tahara T, Shibata T, Wang F, et al. Genetic polymorphisms of molecules associated with innate immune responses, TRL2 and MBL2 genes in Japanese subjects with functional dyspepsia. J Clin Biochem Nutr. 2010;47:217\u201323.","journal-title":"J Clin Biochem Nutr"},{"key":"197_CR80","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0065-2776(08)60790-7","volume":"73","author":"H Wagner","year":"1999","unstructured":"Wagner H. Bacterial CpG DNA activates immune cells to signal infectious danger. Adv Immunol. 1999;73:329\u201368.","journal-title":"Adv Immunol"},{"key":"197_CR81","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","volume":"20","author":"AM Krieg","year":"2002","unstructured":"Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002;20:709\u201360. 85.","journal-title":"Annu Rev Immunol"},{"key":"197_CR82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-199503000-00010","volume":"20","author":"W Holtkamp","year":"1995","unstructured":"Holtkamp W, Stollberg T, Reis HE. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol. 1995;20:123\u20136.","journal-title":"J Clin Gastroenterol"},{"key":"197_CR83","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","volume":"132","author":"T Liebregts","year":"2007","unstructured":"\u2022 Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007; 132:913\u201320. A good study looking at immune activation and inflammation in IBS.","journal-title":"Gastroenterology"},{"key":"197_CR84","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/eji.200636562","volume":"37","author":"AE Anderson","year":"2007","unstructured":"Anderson AE, Worku ML, Khamri W, et al. TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: results from a genome-wide scan. Eur J Immunol. 2007;37:1548\u201361.","journal-title":"Eur J Immunol"},{"key":"197_CR85","first-page":"129","volume":"101","author":"A Pironti","year":"2010","unstructured":"Pironti A, Tadeu V, Pedroni A, et al. Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms. Minerva Med. 2010;101:129\u201334.","journal-title":"Minerva Med"},{"key":"197_CR86","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ajg.2010.55","volume":"105","author":"WD Chey","year":"2010","unstructured":"Chey WD, Nojkov B, Rubenstein JH, et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 2010;105:859\u201365.","journal-title":"Am J Gastroenterol"},{"key":"197_CR87","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrgastro.2010.137","volume":"7","author":"S Khan","year":"2010","unstructured":"Khan S, Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol. 2010;7:565\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-011-0197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-011-0197-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-011-0197-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T20:28:40Z","timestamp":1637612920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-011-0197-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,7]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1007\/s11894-011-0197-5","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,7]]}}}